Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study
Rivkin, S E ; Green, S ; Metch, B ; Cruz, A B ; Abeloff, M D ; Jewell, W R ; Costanzi, J J ; Farrar, W B ; Minton, J P ; Osborne, C K
Journal of clinical oncology, 1994-10, Vol.12 (10), p.2078-2085
[Periódico revisado por pares]
United States: American Society of Clinical Oncology
Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study
RAVDIN, PM ; GREEN, S ; DORR, TM ; MCGUIRE, WL ; FABIAN, C ; PUGH, RP ; CARTER, RD ; RIVKIN, SE ; BORST ; BELT, RJ ; METCH, B ; OSBORNE, CK
Journal of clinical oncology, 1992-08, Vol.10 (8), p.1284-1291
[Periódico revisado por pares]
Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fuorouracil versus methotrexate in advanced squamous-cell carcinoma of the heat and neck : a southwest oncology group study
FORASTIERE, A. A ; METCH, B ; VON HOFF, D. D ; SCHULLER, D. E ; ENSLEY, J. F ; HUTCHINS, L. F ; TRIOZZI, P ; KISH, J. A ; MCCLURE, S ; VONFELDT, E ; WILLIAMSON, S. K
Journal of clinical oncology, 1992, Vol.10 (8), p.1245-1251
[Periódico revisado por pares]